RenovoRx
Stock Forecast, Prediction & Price Target
RenovoRx Financial Estimates
RenovoRx Revenue Estimates
RenovoRx EBITDA Estimates
RenovoRx Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $27.94M Low: $27.94M High: $27.94M avg. 0% | Avg: $12.18M Low: $12.18M High: $12.18M avg. -56.38% | Avg: $5.72M Low: $5.72M High: $5.72M avg. -53.00% | Avg: $63.81M Low: $63.81M High: $63.81M avg. 1013.91% |
Net Income
% change YoY
| $-7.09M N/A | $-9.77M -37.69% | $-10.23M -4.71% | Avg: $-12.00M Low: $-4.83M High: $-3.60M avg. -17.31% | Avg: $-6.58M Low: $-2.57M High: $-411.62K avg. 45.16% | Avg: $-3.60M Low: $-3.60M High: $-3.60M avg. 45.28% | Avg: $12.09M Low: $12.09M High: $12.09M avg. 435.71% |
EBITDA
% change YoY
| $-5.72M N/A | $-9.95M -73.82% | $-11.39M -14.53% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.79 N/A | -$1.08 -36.70% | -$0.99 8.33% | Avg: -$0.41 Low: -$0.47 High: -$0.35 avg. 58.58% | Avg: -$0.15 Low: -$0.25 High: -$0.04 avg. 64.63% | Avg: -$0.35 Low: -$0.35 High: -$0.35 avg. -141.37% | Avg: $1.18 Low: $1.18 High: $1.18 avg. 435.71% |
Operating Expenses
% change YoY
| $5.67M N/A | $9.95M 75.45% | $11.39M 14.53% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is RenovoRx stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 127.21% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -4.83M, average is -12.00M and high is -3.60M.
What is RenovoRx stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 226.13% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $27.94M, average is $27.94M and high is $27.94M.
What is RenovoRx stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 104.38% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.47, average is -$0.41 and high is $-0.35.